< Back to companies

Zentya, a.s. was established by combining the lengthy experience of our team members in the pharmaceutical industry along with a common passion to provide to customers the latest technology in the field of genetic screening. Our ambition is to bring worldwide knowledge and practices in the field of genetics to patients in Slovakia, to help identify and initiate timely treatment of severe genetic diseases. Zentya is one of the leading provider in the segment of genetic screening in Slovakia. We are executive distributor of BGI company (leader in genomics industry). During short period we established our self as reliable company in our sector. We extending our services and portfolio by new innovations to support our customers.

Share
Shareable draft
Get Involved in Zentya

Company Info

Founded
2014
Website
zentya.sk/

Categories

Genetic DisordersDiagnosticsTreatment & TherapeuticsPrecision Medicine

Disease Areas

Technologies

Genetic TestingGenomic SequencingMolecular Diagnostics
Only accessible to MedStartr community members. Join now

What do you think of Zentya?

A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.

Clinical Benefit Potential

The potential for a project to have a large and significant impact on medical care, treatment, or prevention.

Feasibility

The likelihood that this will provide benefit for patients / care givers and that the founders can execute on their vision and plan.

Innovativeness

The distinguishing features, concept, or technology that differentiates the entry compared to others that already exist and are in widespread use.

Fundability

The reviewers' beliefs that the idea is fundable or can make it to sustainability without outside investment.

Scalability

Some great ideas are destined to failure because they are too complex or too expensive. The reviewer should consider the likelihood that a project as explained, or perhaps with some tweaks, could possibly become a worldwide solution within a reasonable time frame.

Presentation Quality

How well the team presented the idea.

Your scores and comments are shown with your review on this company's profile.

Get Involved in Zentya
💬

Hi, I'm Syggy!

MedStartr's AI healthcare innovation superhero. Just click me for whatever you need! 🥰

💬
Hi, I'm Syggy
your healthcare innovation buddy
💬

Ask Syggy anything

What MedStartr is, how it can help you, events, joining...

You're chatting as a visitor: this conversation stays in this browser, isn't linked to any account, and doesn't move over if you join. Join free